tiprankstipranks
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
US Market

Praxis Precision Medicines (PRAX) Financial Statements

454 Followers

Praxis Precision Medicines Financial Overview

Praxis Precision Medicines's market cap is currently ―. The company's EPS TTM is $-15.915; its P/E ratio is -2.53; Praxis Precision Medicines is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-2.31. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 431.00K$ 515.00K$ 468.00K$ 781.00K$ 683.00K
Gross Profit$ 431.00K$ 515.00K$ 468.00K$ 781.00K$ 683.00K
EBIT$ -39.55M$ -26.88M$ -24.63M$ -34.31M$ -37.45M
EBITDA$ -39.30M$ -26.55M$ -24.31M$ -34.00M$ -37.10M
Net Income Common Stockholders$ -39.60M$ -26.88M$ -24.63M$ -34.31M$ -37.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 207.42M$ 81.30M$ 101.10M$ 124.30M$ 85.82M
Total Assets$ 250.41M$ 87.95M$ 106.72M$ 133.50M$ 97.52M
Total Debt$ 2.22M$ 2.50M$ 2.76M$ 3.01M$ 3.26M
Net Debt$ -205.19M$ -78.81M$ -98.34M$ -121.29M$ -82.56M
Total Liabilities$ 20.73M$ 18.28M$ 19.97M$ 27.87M$ 33.91M
Stockholders Equity$ 229.68M$ 69.67M$ 86.76M$ 105.64M$ 64.47M
Cash Flow-
Free Cash Flow$ -20.86M$ -23.91M$ -23.21M$ -31.17M$ -32.89M
Operating Cash Flow$ -20.86M$ -23.86M$ -23.21M$ -31.17M$ -32.89M
Investing Cash Flow$ -91.22M$ -50.00K-$ 5.00M$ 34.00M
Financing Cash Flow$ 182.76M$ 4.13M-$ 69.67M$ 18.07M
Currency in USD

Praxis Precision Medicines Earnings and Revenue History

Praxis Precision Medicines Debt to Assets

Praxis Precision Medicines Cash Flow

Praxis Precision Medicines Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis